【目的】探究丝裂原活化蛋白激酶激酶6(mitogen-activated protein kinase kinase6,MAP2K6)基因在湖羊不同发育阶段背最长肌组织中的表达水平,分析该基因的多态性与湖羊生长性状之间的相关性,以期为湖羊的生长性状分子育种提供新的标记...【目的】探究丝裂原活化蛋白激酶激酶6(mitogen-activated protein kinase kinase6,MAP2K6)基因在湖羊不同发育阶段背最长肌组织中的表达水平,分析该基因的多态性与湖羊生长性状之间的相关性,以期为湖羊的生长性状分子育种提供新的标记资源。【方法】利用实时荧光定量PCR检测MAP2K6基因在湖羊(n=15)不同发育阶段背最长肌组织中的表达情况;通过Illumina OvineSNP 50K BeadChip检测湖羊(n=3024)MAP2K6基因的单核苷酸多态性(SNP),利用一般线性模型分析MAP2K6基因SNP位点与湖羊(n=1974)生长性状间的关联性,并使用R语言corrplot包计算湖羊体重与各体尺指标的相关系数。【结果】实时荧光定量PCR检测结果显示,湖羊背最长肌组织中MAP2K6基因表达量在初生到4月龄阶段逐渐升高,且3、4月龄的表达量均极显著高于初生、45日龄和6月龄(P<0.01)。湖羊MAP2K6基因中共检测到2个位点:rs414959578G>A和rs426057803A>G。关联分析结果显示,MAP2K6基因rs414959578G>A位点对湖羊5月龄体重、体高、体斜长、胸围、胸深、胸宽、十字部高、腰角宽,以及6月龄胸围、背膘厚有显著或极显著影响(P<0.05;P<0.01);rs426057803A>G位点对湖羊3月龄管围,5月龄胸围、管围和十字部高以及6月龄背膘厚有显著或极显著影响(P<0.05;P<0.01)。相关性分析结果显示,湖羊体重与体尺指标间存在显著正相关(P<0.05),但6月龄湖羊体斜长与6月龄胸宽、腰角宽,5月龄管围与6月龄腰角宽均不存在显著相关(P>0.05)。【结论】MAP2K6基因与湖羊背最长肌的发育相关,rs414959578G>A和rs426057803A>G位点对湖羊生长性状有显著影响。研究结果可为湖羊生长性状分子标记的挖掘和利用提供一定的理论依据。展开更多
目的基于T2^(*)mapping定量分析业余马拉松运动员足踝部关节软骨的T2^(*)值,并分析其与性别、年龄、身体质量指数(body mass index,BMI)、跑龄、跑量之间的相关性。材料与方法于2023年7月份至2023年9月份招募重庆市长跑运动爱好者48名,...目的基于T2^(*)mapping定量分析业余马拉松运动员足踝部关节软骨的T2^(*)值,并分析其与性别、年龄、身体质量指数(body mass index,BMI)、跑龄、跑量之间的相关性。材料与方法于2023年7月份至2023年9月份招募重庆市长跑运动爱好者48名,其中跑量<300 km/月的36例(中低跑量组),跑量≥300 km/月的12例(高跑量组)。所有受试者均进行单侧无症状踝关节的MRI扫描,扫描序列包括T2^(*)mapping多回波自旋回波(spin echo,SE)序列矢状位、质子密度加权成像脂肪抑制(proton density-weighted imaging fat-saturated,PDWI-FS)序列矢状位、冠状位、横轴位以及T1加权脂肪抑制成像(T1-weighted imaging fat-saturated,T1WI-FS)序列横轴位。沿关节软骨轮廓边缘勾画距骨穹窿、跟骰关节跟骨面、骰骨面及后距下关节跟骨面、距骨面软骨作为感兴趣区(region of interest,ROI),获得相应的T2^(*)值。采用线性回归分析软骨T2^(*)值与年龄、BMI、跑龄的相关性,采用独立样本t检验分析不同跑量及不同性别间的软骨T2^(*)值差异。结果(1)距骨穹窿、跟骰关节跟骨面及骰骨面、后距下关节跟骨面及距骨面软骨T2^(*)值在性别上的差异均具有统计学意义(P=0.001、P<0.001、P=0.002、P=0.008、P=0.004);(2)高跑量组的距骨穹窿、后距下关节跟骨面软骨T2^(*)值高于中低跑量组(P=0.014、0.023),不同跑量的跟骰关节跟骨面及骰骨面、后距下关节距骨面软骨T2^(*)值的差异均无统计学意义(P=0.987、0.072、0.724);(3)距骨穹窿、跟骰关节跟骨面及骰骨面、后距下关节跟骨面、距骨面软骨T2^(*)值均与BMI呈正相关(r=0.376、0.384、0.300、0.422、0.455,P=0.005、0.004、0.019、0.001、0.001)。结论在业余马拉松运动员这一跑步群体中,与中低跑量相比,高跑量更有可能导致距骨穹窿、后距下关节跟骨面软骨损伤;而与较低的BMI相比,高BMI增加了距骨穹窿、跟骰关节跟骨面、骰骨面及后距下关节跟骨面、距骨面软骨损伤的风险。展开更多
目的探讨心脏磁共振组织追踪(cardiac magnetic resonance tissue tracing,CMR-TT)技术及T1 mapping技术在2型糖尿病(type 2 diabetes mellitus,T2DM)患者心肌损伤评估中的应用价值。材料与方法前瞻性收集2023年12月至2025年4月在我院...目的探讨心脏磁共振组织追踪(cardiac magnetic resonance tissue tracing,CMR-TT)技术及T1 mapping技术在2型糖尿病(type 2 diabetes mellitus,T2DM)患者心肌损伤评估中的应用价值。材料与方法前瞻性收集2023年12月至2025年4月在我院进行心脏磁共振检查的T2DM患者64例,健康对照(healthy controls,HC)32例。所有心脏磁共振图像数据导入专用软件进行分析,获取全心心肌应变参数、双心室功能参数以及左心室T1 mapping参数,采用t检验,Mann-Whitney U检验及卡方检验对两组间上述参数进行比较,采用Pearson及Spearman相关性分析心肌结构、功能与心肌应变的关联。结果T2DM组左心室心肌质量指数(left ventricular myocardial mass index,LVMI)、左心室重塑指数(left ventricular remodeling index,LVRI)增加(均P<0.001),左心室全局纵向应变(global longitudinal peak strain in the left ventricle,LV GLS)、右心室全局纵向应变降低(均P<0.05),T2DM组周向左心室收缩期峰值应变率(peak systolic strain rate of the left ventricle,LV PSSR)、纵向LV PSSR及左心室舒张期峰值应变率(diastolic peak strain rate of the left ventricle,LV PDSR)绝对值均降低(均P<0.019)。T2DM患者左心房/右心房(leftatrium/rightatrium,LA/RA)储存应变、LA/RA导管应变均降低(均P<0.001)。T2DM患者的细胞外容积(extracellular volume,ECV)较HC组升高(P<0.001)。双心室射血分数、收缩末期容积指数与双心室应变功能均相关(均P<0.003)。LVMI与左心室全局径向应变(global radial strain of the left ventricle,LV GRS)、左心室全局周向应变(global circumferential strain of the left ventricle,LV GCS)、LV GLS、周向LV PSSR、纵向LV PSSR、径向LV PDSR、周向LV PDSR、纵向LV PDSR相关(均P<0.021)。左心室舒张末期容积指数与LV GCS、LV GLS、周向LV PSSR、纵向LV PSSR、周向LV PDSR相关(均P<0.044)。右心室舒张末期容积指数与右心室全局周向应变相关(r=0.331,P=0.007)。LVRI与LV GLS及纵向LV PDSR相关(均P<0.01),且与径向LV PSSR弱相关(r=0.266,P=0.034)。结论T2DM患者全心心肌应变较对照组降低,ECV值升高,双心室心肌结构、功能与心肌应变相互关联,CMR-TT及T1 mapping技术可以有效检测糖尿病心肌损伤。展开更多
Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ab...Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ability,the arginine-glycine-aspartic(RGD)peptide and the epidermal growth factor receptor interference(EGFRi)peptide were fused with MAP30,which was named ELRL-MAP30.The efficiency of targeted therapy for triple-negative breast cancer(TNBC)MDA-MB-231 cells,which lack the expression of estrogen receptor(ER),Progesterone receptor(PgR)and human epidermal growth factor receptor-2(HER2),is limited.In this study,we focus on exploring the effect and mechanism of ELRL-MAP30 on TNBC MDA-MB-231 cells.First,we discovered that ELRL-MAP30 significantly inhibited the migration and invasion of MDA-MB-231 cells and induced MDA-MB-231 cell apoptosis.Moreover,ELRL-MAP30 treatment resulted in a significant increase in Bax expression and a decrease in Bcl-2 expression.Furthermore,ELRL-MAP30 triggered apoptosis via the Fak/EGFR/Erk and Ilk/Akt signaling pathways.In addition,recombinant ELRL-MAP30 can inhibit chicken embryonic angiogenesis,and also inhibit the tube formation ability of human umbilical vein endothelial cells(HUVECs),indicating its potential therapeutic effects on tumor angiogenesis.Collectively,these results indicate that ELRL-MAP30 has significant tumor-targeting properties in MDA-MB-231 cancer cells and reveals potential therapeutic effects on angiogenesis.These findings indicate the potential role of ELRL-MAP30 in the targeted treatment of the TNBC cell line MDA-MB-231.展开更多
文摘目的探讨心脏磁共振组织追踪(cardiac magnetic resonance tissue tracing,CMR-TT)技术及T1 mapping技术在2型糖尿病(type 2 diabetes mellitus,T2DM)患者心肌损伤评估中的应用价值。材料与方法前瞻性收集2023年12月至2025年4月在我院进行心脏磁共振检查的T2DM患者64例,健康对照(healthy controls,HC)32例。所有心脏磁共振图像数据导入专用软件进行分析,获取全心心肌应变参数、双心室功能参数以及左心室T1 mapping参数,采用t检验,Mann-Whitney U检验及卡方检验对两组间上述参数进行比较,采用Pearson及Spearman相关性分析心肌结构、功能与心肌应变的关联。结果T2DM组左心室心肌质量指数(left ventricular myocardial mass index,LVMI)、左心室重塑指数(left ventricular remodeling index,LVRI)增加(均P<0.001),左心室全局纵向应变(global longitudinal peak strain in the left ventricle,LV GLS)、右心室全局纵向应变降低(均P<0.05),T2DM组周向左心室收缩期峰值应变率(peak systolic strain rate of the left ventricle,LV PSSR)、纵向LV PSSR及左心室舒张期峰值应变率(diastolic peak strain rate of the left ventricle,LV PDSR)绝对值均降低(均P<0.019)。T2DM患者左心房/右心房(leftatrium/rightatrium,LA/RA)储存应变、LA/RA导管应变均降低(均P<0.001)。T2DM患者的细胞外容积(extracellular volume,ECV)较HC组升高(P<0.001)。双心室射血分数、收缩末期容积指数与双心室应变功能均相关(均P<0.003)。LVMI与左心室全局径向应变(global radial strain of the left ventricle,LV GRS)、左心室全局周向应变(global circumferential strain of the left ventricle,LV GCS)、LV GLS、周向LV PSSR、纵向LV PSSR、径向LV PDSR、周向LV PDSR、纵向LV PDSR相关(均P<0.021)。左心室舒张末期容积指数与LV GCS、LV GLS、周向LV PSSR、纵向LV PSSR、周向LV PDSR相关(均P<0.044)。右心室舒张末期容积指数与右心室全局周向应变相关(r=0.331,P=0.007)。LVRI与LV GLS及纵向LV PDSR相关(均P<0.01),且与径向LV PSSR弱相关(r=0.266,P=0.034)。结论T2DM患者全心心肌应变较对照组降低,ECV值升高,双心室心肌结构、功能与心肌应变相互关联,CMR-TT及T1 mapping技术可以有效检测糖尿病心肌损伤。
文摘Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ability,the arginine-glycine-aspartic(RGD)peptide and the epidermal growth factor receptor interference(EGFRi)peptide were fused with MAP30,which was named ELRL-MAP30.The efficiency of targeted therapy for triple-negative breast cancer(TNBC)MDA-MB-231 cells,which lack the expression of estrogen receptor(ER),Progesterone receptor(PgR)and human epidermal growth factor receptor-2(HER2),is limited.In this study,we focus on exploring the effect and mechanism of ELRL-MAP30 on TNBC MDA-MB-231 cells.First,we discovered that ELRL-MAP30 significantly inhibited the migration and invasion of MDA-MB-231 cells and induced MDA-MB-231 cell apoptosis.Moreover,ELRL-MAP30 treatment resulted in a significant increase in Bax expression and a decrease in Bcl-2 expression.Furthermore,ELRL-MAP30 triggered apoptosis via the Fak/EGFR/Erk and Ilk/Akt signaling pathways.In addition,recombinant ELRL-MAP30 can inhibit chicken embryonic angiogenesis,and also inhibit the tube formation ability of human umbilical vein endothelial cells(HUVECs),indicating its potential therapeutic effects on tumor angiogenesis.Collectively,these results indicate that ELRL-MAP30 has significant tumor-targeting properties in MDA-MB-231 cancer cells and reveals potential therapeutic effects on angiogenesis.These findings indicate the potential role of ELRL-MAP30 in the targeted treatment of the TNBC cell line MDA-MB-231.
